Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 70.47 USD 0.03% Market Closed
Market Cap: 5B USD

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 144.07 USD with a low forecast of 76.1 USD and a high forecast of 182.69 USD.

Lowest
Price Target
76.1 USD
8% Upside
Average
Price Target
144.07 USD
104% Upside
Highest
Price Target
182.69 USD
159% Upside
Zealand Pharma A/S Competitors:
Price Targets
SPRY
ARS Pharmaceuticals Inc
123% Upside
EDIT
Editas Medicine Inc
89% Upside
MRUS
Merus NV
56% Upside
PYC
PYC Therapeutics Ltd
190% Upside
301207
Hualan Biological Bacterin Inc
16% Upside
KRYS
Krystal Biotech Inc
67% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
4% Upside
688293
Shanghai OPM Biosciences Co Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

-15%
Past Growth
205%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
144.07 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 144.07 USD with a low forecast of 76.1 USD and a high forecast of 182.69 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
205%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

Back to Top